Published in Biochem Biophys Res Commun on March 18, 2008
RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med (2009) 2.56
The many substrates of presenilin/γ-secretase. J Alzheimers Dis (2011) 2.02
Trafficking of receptor tyrosine kinases to the nucleus. Exp Cell Res (2008) 1.33
Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene. FASEB J (2009) 1.23
Microglia activation and anti-inflammatory regulation in Alzheimer's disease. Mol Neurobiol (2010) 1.22
RAGE: the beneficial and deleterious effects by diverse mechanisms of actions. Mol Cells (2011) 1.15
Lessons from in vitro studies and a related intracellular angiotensin II transgenic mouse model. Am J Physiol Regul Integr Comp Physiol (2011) 1.08
Alternatively spliced RAGEv1 inhibits tumorigenesis through suppression of JNK signaling. Cancer Res (2010) 0.95
Statins stimulate the production of a soluble form of the receptor for advanced glycation end products. J Lipid Res (2013) 0.91
Association of the receptor for advanced glycation end products gene polymorphisms and circulating RAGE levels with diabetic retinopathy in the Chinese population. J Diabetes Res (2013) 0.90
Arterial calcification is driven by RAGE in Enpp1-/- mice. J Vasc Res (2010) 0.89
Receptor for advanced glycation end products: its role in Alzheimer's disease and other neurological diseases. Future Neurol (2009) 0.87
Solution structure of the soluble receptor for advanced glycation end products (sRAGE). J Biol Chem (2011) 0.87
Induction of RAGE shedding by activation of G protein-coupled receptors. PLoS One (2012) 0.87
The S100B/RAGE Axis in Alzheimer's Disease. Cardiovasc Psychiatry Neurol (2010) 0.86
Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease? Int J Alzheimers Dis (2012) 0.82
Regulation of Receptor for Advanced Glycation End Products (RAGE) Ectodomain Shedding and Its Role in Cell Function. J Biol Chem (2016) 0.80
Expression of a naturally occurring angiotensin AT(1) receptor cleavage fragment elicits caspase-activation and apoptosis. Am J Physiol Cell Physiol (2011) 0.80
Soluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary Syndrome. Biomed Res Int (2015) 0.79
Ectodomain shedding of interleukin-2 receptor beta and generation of an intracellular functional fragment. J Biol Chem (2010) 0.79
Reasons to Investigate the Soluble Receptor for Advanced Glycation End-Product (sRAGE) Pathway in Aortic Disease. Aorta (Stamford) (2013) 0.78
Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study. Cardiovasc Diabetol (2015) 0.78
Mouse Specific Cleavage-Resistant RAGE Splice Variant. PLoS One (2016) 0.75
The Mouse-Specific Splice Variant mRAGE_v4 Encodes a Membrane-Bound RAGE That Is Resistant to Shedding and Does Not Contribute to the Production of Soluble RAGE. PLoS One (2016) 0.75
S100A12 is up-regulated in pulmonary tuberculosis and predicts the extent of alveolar infiltration on chest radiography: an observational study. Sci Rep (2016) 0.75
Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes. PLoS One (2015) 0.75
Mouse RAGE Variant 4 Is a Dominant Membrane Receptor that Does Not Shed to Generate Soluble RAGE. PLoS One (2016) 0.75
S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun (2004) 3.38
Mass spectrometry: a tool for enhanced detection of hemoglobin variants. Clin Chem (2007) 2.11
Binding of S100 proteins to RAGE: an update. Biochim Biophys Acta (2008) 2.00
The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer. Gastroenterology (2006) 1.73
Structural and functional insights into RAGE activation by multimeric S100B. EMBO J (2007) 1.59
The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units. Biochemistry (2007) 1.51
S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J Biol Chem (2007) 1.49
Distinct migratory behavior of early- and late-born neurons derived from the cortical ventricular zone. J Comp Neurol (2004) 1.47
The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity. J Biol Chem (2005) 1.44
Structure of the Ca2+/S100B/NDR kinase peptide complex: insights into S100 target specificity and activation of the kinase. Biochemistry (2003) 1.30
Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma. Cancer Lett (2005) 1.19
Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays. Biochem Biophys Res Commun (2003) 1.19
Site-specific blockade of RAGE-Vd prevents amyloid-beta oligomer neurotoxicity. J Neurosci (2008) 1.15
Molecular cloning and characterization of the human S100A14 gene encoding a novel member of the S100 family. Genomics (2002) 1.13
S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells. Biochem Biophys Res Commun (2004) 1.11
Cancer predisposition in mice deficient for the metastasis-associated Mts1(S100A4) gene. Oncogene (2004) 1.09
Mitochondrial matrix calcium is an activating signal for hormone secretion. Cell Metab (2011) 1.06
An update of the S100 nomenclature. Biochim Biophys Acta (2006) 1.05
Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes. Cancer Sci (2005) 1.03
RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis. Oncotarget (2014) 1.03
Ca2+ -dependent interaction of S100A1 with the sarcoplasmic reticulum Ca2+ -ATPase2a and phospholamban in the human heart. Biochem Biophys Res Commun (2003) 1.02
Calcium, troponin, calmodulin, S100 proteins: from myocardial basics to new therapeutic strategies. Biochem Biophys Res Commun (2007) 1.00
S100 and S100 fused-type protein families in epidermal maturation with special focus on S100A3 in mammalian hair cuticles. Biochimie (2011) 0.94
Extracellular S100A4 stimulates the migration rate of astrocytic tumor cells by modifying the organization of their actin cytoskeleton. Biochim Biophys Acta (2002) 0.94
Implications on zinc binding to S100A2. Biochim Biophys Acta (2006) 0.93
S100A16, a novel calcium-binding protein of the EF-hand superfamily. J Biol Chem (2006) 0.93
Astrocytic calcium/zinc binding protein S100A6 over expression in Alzheimer's disease and in PS1/APP transgenic mice models. Biochim Biophys Acta (2004) 0.92
S100A4 regulates E-cadherin expression in oral squamous cell carcinoma. Cancer Lett (2005) 0.92
The crystal structures of human S100B in the zinc- and calcium-loaded state at three pH values reveal zinc ligand swapping. Biochim Biophys Acta (2010) 0.91
Expression and purification of the soluble isoform of human receptor for advanced glycation end products (sRAGE) from Pichia pastoris. Biochem Biophys Res Commun (2006) 0.90
Correlation of S100A4 expression with invasion and metastasis in oral squamous cell carcinoma. Oral Oncol (2004) 0.90
Specific citrullination causes assembly of a globular S100A3 homotetramer: a putative Ca2+ modulator matures human hair cuticle. J Biol Chem (2007) 0.89
The crystal structure of metal-free human EF-hand protein S100A3 at 1.7-A resolution. J Biol Chem (2002) 0.88
Crosstalk between calcium, amyloid beta and the receptor for advanced glycation endproducts in Alzheimer's disease. Rev Neurosci (2009) 0.86
Analysis of minor hemoglobins by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem (2005) 0.86
RAGE and S100 protein transcription levels are highly variable in human melanoma tumors and cells. Gen Physiol Biophys (2009) 0.86
S100A6 overexpression within astrocytes associated with impaired axons from both ALS mouse model and human patients. J Neuropathol Exp Neurol (2002) 0.86
Ca2+ signaling in mouse cardiomyocytes with ablated S100A1 protein. Gen Physiol Biophys (2009) 0.84
Purification, crystallization and preliminary X-ray diffraction studies on human Ca2+-binding protein S100B. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.84
S100A16, a ubiquitously expressed EF-hand protein which is up-regulated in tumors. Biochem Biophys Res Commun (2004) 0.84
S100A13 and S100A6 exhibit distinct translocation pathways in endothelial cells. J Cell Sci (2002) 0.84
RAGE does not affect amyloid pathology in transgenic ArcAbeta mice. Neurodegener Dis (2010) 0.84
S100A1-deficient male mice exhibit increased exploratory activity and reduced anxiety-related responses. Biochim Biophys Acta (2006) 0.83
The importance of Ca2+/Zn2+ signaling S100 proteins and RAGE in translational medicine. Front Biosci (Schol Ed) (2011) 0.83
N(epsilon)-carboxymethyllysine-modified proteins are unable to bind to RAGE and activate an inflammatory response. Mol Nutr Food Res (2008) 0.83
Human S100A3 tetramerization propagates Ca(2+)/Zn(2+) binding states. Biochim Biophys Acta (2012) 0.83
Metal-free MIRAS phasing: structure of apo-S100A3. Acta Crystallogr D Biol Crystallogr (2002) 0.83
S100B Protein in the Nervous System and Cardiovascular Apparatus in Normal and Pathological Conditions. Cardiovasc Psychiatry Neurol (2010) 0.81
Glycolaldehyde-modified β-lactoglobulin AGEs are unable to stimulate inflammatory signaling pathways in RAGE-expressing human cell lines. Mol Nutr Food Res (2010) 0.81
Differential expression of S100 proteins in the developing human hippocampus and temporal cortex. Microsc Res Tech (2003) 0.80
Refined crystal structures of human Ca(2+)/Zn(2+)-binding S100A3 protein characterized by two disulfide bridges. J Mol Biol (2011) 0.80
Effect of glycosylation on the protein pattern in 2-D-gel electrophoresis. Proteomics (2007) 0.79
Purification and characterization of the human cysteine-rich S100A3 protein and its pseudo citrullinated forms expressed in insect cells. Methods Mol Biol (2013) 0.79
Dissimilar effect of perming and bleaching treatments on cuticles: advanced hair damage model based on elution and oxidation of S100A3 protein. J Cosmet Sci (2005) 0.78
Diminished expression of S100A2, a putative tumour suppressor, is an independent predictive factor of neck node relapse in laryngeal squamous cell carcinoma. J Otolaryngol Head Neck Surg (2009) 0.78
Free 3-nitrotyrosine in exhaled breath condensates of children fails as a marker for oxidative stress in stable cystic fibrosis and asthma. Nitric Oxide (2006) 0.78
Detection of a novel variant human hemoglobin by electrospray ionization mass spectrometry. Biochem Biophys Res Commun (2002) 0.77
Pathfinding and growth termination of primary trigeminal sensory afferents in the embryonic rat hindbrain. J Comp Neurol (2003) 0.77
Detection of S100B, S100A6 and galectin-3 ligands in meningiomas as markers of aggressiveness. Int J Oncol (2004) 0.77
Effects of creatine supplementation in cystic fibrosis: results of a pilot study. J Cyst Fibros (2003) 0.76
Postnatal maturation of the dog stria vascularis-- an immunohistochemical study. Anat Rec A Discov Mol Cell Evol Biol (2003) 0.75
The 10th European symposium on calcium-binding proteins in normal and transformed cells. Biochim Biophys Acta (2009) 0.75
Mass spectrometric analysis of human transferrin in different body fluids. Clin Chem Lab Med (2003) 0.75
Characterization of the cysteine-rich calcium-binding S100A3 protein from human hair cuticles. Biochem Biophys Res Commun (2002) 0.75
Calbindin-d(28k): a marker of recurrence for medulloblastomas. Cancer (2002) 0.75
The 11(th) Meeting of the European Calcium Society. Biochim Biophys Acta (2011) 0.75